E975-1531 Screening compound: N-(4-bromo-2-fluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide

E975-1531 Screening compound: N-(4-bromo-2-fluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide
E975-1531 Screening compound: N-(4-bromo-2-fluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E975-1531
N-(4-bromo-2-fluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E975-1531

Molecular Formula

C15H12BrFN2O3S2 (C15 H12 BrFN2 O3 S2)

Compound Name

N-(4-bromo-2-fluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide

IUPAC name

N-(4-bromo-2-fluorophenyl)-4-oxo-2345-tetrahydro-15-benzothiazepine-7-sulfonamide

SMILES

O=C1Nc(cc(cc2)S(Nc(ccc(Br)c3)c3F)(=O)=O)c2SCC1

InChI

InChI=1S/C15H12BrFN2O3S2/c16-9-1-3-12(11(17)7-9)19-24(21,22)10-2-4-14-13(8-10)18-15(20)5-6-23-14/h1-4,7-8,19H,5-6H2,(H,18,20)

InChI Key

YGRFPMYAEJALQC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14934320

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.31

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.305

Distribution Coefficient, logD

0.857

Water Solubility, LogSw

-3.72

Polar Surface Area

65.342

Acid Dissociation Constant (pKa)

4.95

Base Dissociation Constant (pKb)

-3.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.30

E975-1531 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E975-1531 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E975-1531?
Check Price and Availability of E975-1531, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E975-1531 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E975-1531
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E975-1531
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E975-1531 available by request